Your browser doesn't support javascript.
loading
Clinic and genetic predictors in response to erenumab.
Zecca, Chiara; Cargnin, Sarah; Schankin, Christoph; Giannantoni, Nadia Mariagrazia; Viana, Michele; Maraffi, Isabella; Riccitelli, Gianna Carla; Sihabdeen, Shairin; Terrazzino, Salvatore; Gobbi, Claudio.
Afiliación
  • Zecca C; Department of Neurology, Neurocenter of Southern Switzerland, Ospedale Regionale di Lugano, EOC, Lugano, Switzerland.
  • Cargnin S; Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland.
  • Schankin C; Department of Pharmaceutical Sciences and Interdepartmental Research Center of Pharmacogenetics and Pharmacogenomics (CRIFF), University of Piemonte Orientale "A. Avogadro", Novara, Italy.
  • Giannantoni NM; Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Viana M; Department of Neurology, Neurocenter of Southern Switzerland, Ospedale Regionale di Lugano, EOC, Lugano, Switzerland.
  • Maraffi I; Department of Neurology, Neurocenter of Southern Switzerland, Ospedale Regionale di Lugano, EOC, Lugano, Switzerland.
  • Riccitelli GC; Department of Neurology, Neurocenter of Southern Switzerland, Ospedale Regionale di Lugano, EOC, Lugano, Switzerland.
  • Sihabdeen S; Department of Neurology, Neurocenter of Southern Switzerland, Ospedale Regionale di Lugano, EOC, Lugano, Switzerland.
  • Terrazzino S; Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland.
  • Gobbi C; Department of Neurology, Neurocenter of Southern Switzerland, Ospedale Regionale di Lugano, EOC, Lugano, Switzerland.
Eur J Neurol ; 29(4): 1209-1217, 2022 04.
Article en En | MEDLINE | ID: mdl-34965002
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anticuerpos Monoclonales Humanizados / Trastornos Migrañosos Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Neurol Asunto de la revista: NEUROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anticuerpos Monoclonales Humanizados / Trastornos Migrañosos Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Neurol Asunto de la revista: NEUROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Reino Unido